Prospects for Adding Drugs with Known Anti-tuberculosis Activity to the Composition of Bone Cement for Treatment of Tuberculous Arthritis

The objective: to evaluate the possibility of using linezolid, amikacin, levofloxacin and bedaquiline mixed with bone cement for the treatment of patients with tuberculous arthritis taking into account changes in mechanical properties of bone cement, antimycobacterial activity of drugs and character...

Full description

Saved in:
Bibliographic Details
Main Authors: E. O. Peretsmanas, V. S. Zubikov, A. E. Panova, A. N. Gracheva, A. A. Kazyulina, I. A. Gerasimov
Format: Article
Language:Russian
Published: New Terra Publishing House 2022-10-01
Series:Туберкулез и болезни лёгких
Subjects:
Online Access:https://www.tibl-journal.com/jour/article/view/1674
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850283869813604352
author E. O. Peretsmanas
V. S. Zubikov
A. E. Panova
A. N. Gracheva
A. A. Kazyulina
I. A. Gerasimov
author_facet E. O. Peretsmanas
V. S. Zubikov
A. E. Panova
A. N. Gracheva
A. A. Kazyulina
I. A. Gerasimov
author_sort E. O. Peretsmanas
collection DOAJ
description The objective: to evaluate the possibility of using linezolid, amikacin, levofloxacin and bedaquiline mixed with bone cement for the treatment of patients with tuberculous arthritis taking into account changes in mechanical properties of bone cement, antimycobacterial activity of drugs and characteristics of their release.Subjects and Methods. The antimycobacterial, elution and strength characteristics of bone cement mixed with the drugs known for their anti-tuberculosis activity were studied: linezolid, amikacin, levofloxacin, and bedaquiline. The antimycobacterial effect was evaluated by the minimum inhibitory concentration (MIC) of the reference strain of Mycobacterium tuberculosis H37RV sensitive to anti-tuberculosis drugs (TB drugs). To study the kinetics of elution, the methods of high-performance mass spectrometry and spectrophotometry were used. The strength characteristics were determined using LFM-50 electromechanical testing machine.Results. The obtained results demonstrated satisfactory elution and antimycobacterial parameters for linezolid and amikacin, thus they can be mixed with bone cement, and the cement retained its strength characteristics. Levofloxacin showed antimycobacterial activity only within 1 day after the cement sample was immersed in the solution. Bedaquiline showed negative elution and antimycobacterial characteristics in the cement sample.
format Article
id doaj-art-e6ec0c898fbe403e8415c0b10bf18fbf
institution OA Journals
issn 2075-1230
2542-1506
language Russian
publishDate 2022-10-01
publisher New Terra Publishing House
record_format Article
series Туберкулез и болезни лёгких
spelling doaj-art-e6ec0c898fbe403e8415c0b10bf18fbf2025-08-20T01:47:41ZrusNew Terra Publishing HouseТуберкулез и болезни лёгких2075-12302542-15062022-10-011009273310.21292/2075-1230-2022-100-9-27-331669Prospects for Adding Drugs with Known Anti-tuberculosis Activity to the Composition of Bone Cement for Treatment of Tuberculous ArthritisE. O. Peretsmanas0V. S. Zubikov1A. E. Panova2A. N. Gracheva3A. A. Kazyulina4I. A. Gerasimov5National Medical Research Center of Phthisiopulmonology and Infectious DiseasesNational Medical Research Center of Phthisiopulmonology and Infectious DiseasesNational Medical Research Center of Phthisiopulmonology and Infectious DiseasesNational Medical Research Center of Phthisiopulmonology and Infectious DiseasesNational Medical Research Center of Phthisiopulmonology and Infectious DiseasesNational Medical Research Center of Phthisiopulmonology and Infectious DiseasesThe objective: to evaluate the possibility of using linezolid, amikacin, levofloxacin and bedaquiline mixed with bone cement for the treatment of patients with tuberculous arthritis taking into account changes in mechanical properties of bone cement, antimycobacterial activity of drugs and characteristics of their release.Subjects and Methods. The antimycobacterial, elution and strength characteristics of bone cement mixed with the drugs known for their anti-tuberculosis activity were studied: linezolid, amikacin, levofloxacin, and bedaquiline. The antimycobacterial effect was evaluated by the minimum inhibitory concentration (MIC) of the reference strain of Mycobacterium tuberculosis H37RV sensitive to anti-tuberculosis drugs (TB drugs). To study the kinetics of elution, the methods of high-performance mass spectrometry and spectrophotometry were used. The strength characteristics were determined using LFM-50 electromechanical testing machine.Results. The obtained results demonstrated satisfactory elution and antimycobacterial parameters for linezolid and amikacin, thus they can be mixed with bone cement, and the cement retained its strength characteristics. Levofloxacin showed antimycobacterial activity only within 1 day after the cement sample was immersed in the solution. Bedaquiline showed negative elution and antimycobacterial characteristics in the cement sample.https://www.tibl-journal.com/jour/article/view/1674bone cementanti-tuberculosis drugselutionstrength characteristicsantimycobacterial activity
spellingShingle E. O. Peretsmanas
V. S. Zubikov
A. E. Panova
A. N. Gracheva
A. A. Kazyulina
I. A. Gerasimov
Prospects for Adding Drugs with Known Anti-tuberculosis Activity to the Composition of Bone Cement for Treatment of Tuberculous Arthritis
Туберкулез и болезни лёгких
bone cement
anti-tuberculosis drugs
elution
strength characteristics
antimycobacterial activity
title Prospects for Adding Drugs with Known Anti-tuberculosis Activity to the Composition of Bone Cement for Treatment of Tuberculous Arthritis
title_full Prospects for Adding Drugs with Known Anti-tuberculosis Activity to the Composition of Bone Cement for Treatment of Tuberculous Arthritis
title_fullStr Prospects for Adding Drugs with Known Anti-tuberculosis Activity to the Composition of Bone Cement for Treatment of Tuberculous Arthritis
title_full_unstemmed Prospects for Adding Drugs with Known Anti-tuberculosis Activity to the Composition of Bone Cement for Treatment of Tuberculous Arthritis
title_short Prospects for Adding Drugs with Known Anti-tuberculosis Activity to the Composition of Bone Cement for Treatment of Tuberculous Arthritis
title_sort prospects for adding drugs with known anti tuberculosis activity to the composition of bone cement for treatment of tuberculous arthritis
topic bone cement
anti-tuberculosis drugs
elution
strength characteristics
antimycobacterial activity
url https://www.tibl-journal.com/jour/article/view/1674
work_keys_str_mv AT eoperetsmanas prospectsforaddingdrugswithknownantituberculosisactivitytothecompositionofbonecementfortreatmentoftuberculousarthritis
AT vszubikov prospectsforaddingdrugswithknownantituberculosisactivitytothecompositionofbonecementfortreatmentoftuberculousarthritis
AT aepanova prospectsforaddingdrugswithknownantituberculosisactivitytothecompositionofbonecementfortreatmentoftuberculousarthritis
AT angracheva prospectsforaddingdrugswithknownantituberculosisactivitytothecompositionofbonecementfortreatmentoftuberculousarthritis
AT aakazyulina prospectsforaddingdrugswithknownantituberculosisactivitytothecompositionofbonecementfortreatmentoftuberculousarthritis
AT iagerasimov prospectsforaddingdrugswithknownantituberculosisactivitytothecompositionofbonecementfortreatmentoftuberculousarthritis